28.07.2021 • News

Brenntag Closes China Purchases

Brenntag has completed two purchases in China within its Specialties division. On Jul. 23, it closed the acquisition of the first tranche – 67% - of food ingredients specialist Zhongbai Xingye. Purchase of the second tranche – and full acquisition – of the Beijing-based company is expected to be finalized by the end of 2024.

In addition, at the end of June, Brenntag took full control of pigments and additives specialist Wellstar Group with the purchase of the remaining 49% of the business. The German multinational distributor bought the first 51% stake in Wellstar in 2017, operating the business as a joint venture until it took over the remaining shareholding.

“Strengthening our Brenntag Specialties division, particularly in China, as well as in the Asia-Pacific region in general, is a central pillar of our company’s M&A strategy. I am particularly delighted that we stuck exactly to our timing in both cases and were able to successfully close the important acquisition steps in the dynamic and growing Asian markets as planned,” said Henri Nejade, member of the management board of Brenntag and chief operating officer of Brenntag Specialties.

Zhongbai Xingye is dedicated to the distribution of a wide range of specialty food ingredients, including dairy products and proteins. Brenntag said its purchase of the leading player in mainland China is an important step to become a full-line distributor of food ingredients in the Asian market.

Headquartered in Hong Kong, the Wellstar Group operates three subsidiaries in mainland China – in Shenzhen, Guangzhou and Shanghai – supplying high-performance pigments, effect pigments, resins and kaolin used in a broad variety of industries, including coatings, inks, plastic and cosmetics. It also has an application lab for coatings.

Author: Elaine Burridge, Freelance Journalist

Brenntag has completed two purchases in China within its Specialties division....
Brenntag has completed two purchases in China within its Specialties division. The acquisition of the first tranche – 67% - of Zhongbai Xingye closed on Jul. 23; the second tranche is due to close by end 2024. The distributor also took full control of Wellstar Group at end June. (c) Brenntag

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read